Innovative Digital Platform Koneksa's advanced platform integrates digital biomarkers, wearable sensor data, and patient-reported outcomes to deliver real-time, actionable insights, presenting opportunities to collaborate on innovative digital health solutions and data analytics services.

Active Industry Collaborations Recent partnerships with institutions like Nyproton and Merck demonstrate Koneksa's strong presence in clinical research, especially in oncology and neurology, indicating opportunities for expanding collaborations in sophisticated biomarker development and clinical trial support.

Focus on Neuroscience Koneksa's dedicated efforts in neuroscience research, including Parkinson's disease studies and EEG biomarker development, open pathways for sales of specialized digital tools and platforms tailored to neurodegenerative disease monitoring.

Growing Market Reach With revenues between 10 and 25 million dollars and a remote-first, patient-centric approach, Koneksa is positioned to scale its services, enabling partners to tap into a growing market demand for real-world evidence and decentralized clinical trials.

Leadership and Innovation Recent strategic hires and technological launches highlight Koneksa’s commitment to advancing digital health technologies, creating prospects for sales of licensing, platform integration, and custom development projects aligned with their innovation trajectory.